J Korean Med Sci.  2024 Apr;39(12):e122. 10.3346/jkms.2024.39.e122.

The Burden of Clostridioides difficile Infection in Korea

• Jeon SR

• KMID: 2554213
• DOI: http://doi.org/10.3346/jkms.2024.39.e122

Reference

1. Guh AY, Mu Y, Winston LG, Johnston H, Olson D, Farley MM, et al. Emerging Infections Program Clostridioides difficile Infection Working Group. Trends in U.S. burden of Clostridioides difficile infection and outcomes. N Engl J Med. 2020; 382(14):1320–1330. PMID: 32242357.

2. Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011; 365(18):1693–1703. PMID: 22047560.

3. Jun YK, Koh SJ, Myung DS, Park SH, Ooi CJ, Sood A, et al. Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting. Intest Res. 2023; 21(3):353–362. PMID: 37533266.

4. Son KJ, Kim YA, Park YS. The trend of clostridioides difficile infection in Korean hospitals with the analysis of nationwide sample cohort. Ann Clin Microbiol. 2020; 23(4):241–249.

5. Kim J, Myung R, Kim B, Kim J, Kim T, Lee MS, et al. Incidence of Clostridioides difficile infections in Republic of Korea: a prospective study with active surveillance vs. national data from Health Insurance Review & Assessment Service. J Korean Med Sci. 2024; 39(12):e118.

6. Centers for Disease Control and Prevention. Emerging Infections Program, Healthcare-Associated Infections – Community Interface Surveillance Report, Clostridioides difficile infection (CDI), 2021. 2023. Accessed March 15, 2024. https://www.cdc.gov/hai/eip/Annual-CDI-Report-2021 .